Doctors are using new technologies to help boost organ transplant surgeries in the US that are now at a record high. » Read More
The "Halftime Report" traders give three under-the-radar trades for the second half of the day.
Shire, the specialty pharma company, may need to find an antidote for a poison pill before it can win shareholders in Baxalta over to its $30bn bid.
Innovation has always been the blood pumping through the body of the pharma industry, but in recent years the supply seemed to be getting poorer.
The federal government says health care facilities should stop using Hospira's Symbiq medication infusion pump because its vulnerable to hacking.
Ebola briefly returned to the headlines this week with a scare at a hospital in New York, but the deadly virus continues to claim victims in West Africa.
A man bitten by a rattlesnake this month says he received a $153,000 hospital bill.
As sports grapples with the effects of injuries, one area of medicine is looking to make pain and recovery a thing of the past.
Hospitals are taking on Yelp with their own ratings and review system.
GE Vice Chairman John Rice says public private partnerships can help provide solutions to today's toughest health-care challenges.
An Australian spent four days in hospital after her skinny jeans caused her to collapse, NBC News reports.
Nearly 75 percent percent of Humana’s revenue comes from Medicare, more than the other big insurers. Here's why Humana is such a hot commodity.
Consolidation in the health insurance industry is "potentially dangerous" for the hospital business, Mount Sinai Health System's CEO said Thursday.
There have only been four flu pandemics since the start of the 20th century, yet concerns are widening about the potential for a new outbreak.
As the government program reaches the half-century mark, it needs to get into the digital age, says this University of Rochester professor.
This company is setting itself apart from other health insurers by emphasizing technology, data and its easy-to-understand services.
Johnson & Johnson will become the first pharmaceutical company to formally seek advice from outside medical ethicists on "compassionate use" requests.
Get the best of CNBC in your inbox